Kanker Payudara

Jordan’s Humanitarian Beacon: WHO Director-General Strengthens Global Health Partnerships During Landmark State Visit

• Global Breast Cancer Awareness

Jordan’s Humanitarian Beacon: WHO Director-General Strengthens Global Health Partnerships During Landmark State Visit

Reynand Wu October 11, 2026

AMMAN, Jordan – The World Health Organization (WHO) Director-General, Dr. Tedros Adhanom Ghebreyesus, has concluded a pivotal...

Read More Read more about Jordan’s Humanitarian Beacon: WHO Director-General Strengthens Global Health Partnerships During Landmark State Visit

Beyond the Diagnosis: Navigating the Path to Wellness After Breast Cancer Treatment

• Global Breast Cancer Awareness

Beyond the Diagnosis: Navigating the Path to Wellness After Breast Cancer Treatment

Asep Darmawan October 11, 2026

For many patients, the end of active breast cancer treatment—the final infusion or the last radiation session—is...

Read More Read more about Beyond the Diagnosis: Navigating the Path to Wellness After Breast Cancer Treatment

Unmasking Cancer’s Master Manipulator: OU Research Reveals How Aggressive Breast Tumors Hijack the Immune System to Fuel Growth

• Medical Research and Clinical Trials

Unmasking Cancer’s Master Manipulator: OU Research Reveals How Aggressive Breast Tumors Hijack the Immune System to Fuel Growth

Evan Lee Salim October 10, 2026

NORMAN, OK – In a significant stride for cancer research, scientists at the University of Oklahoma (OU)...

Read More Read more about Unmasking Cancer’s Master Manipulator: OU Research Reveals How Aggressive Breast Tumors Hijack the Immune System to Fuel Growth

Alumis Poised to Enter Crowded Psoriasis Market with Promising TYK2 Inhibitor, Envudeucitinib

• Medical Research and Clinical Trials

Alumis Poised to Enter Crowded Psoriasis Market with Promising TYK2 Inhibitor, Envudeucitinib

Nana Wu October 10, 2026

California-based biopharmaceutical company Alumis is making significant strides towards the launch of its novel oral psoriasis treatment,...

Read More Read more about Alumis Poised to Enter Crowded Psoriasis Market with Promising TYK2 Inhibitor, Envudeucitinib

Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Deep Dive into Emerging Research

• Patient Advocacy and Support

Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Deep Dive into Emerging Research

Jia Lissa October 10, 2026

By Douglas Feil, NBCF Chief Program Officer In recent years, glucagon-like peptide-1 (GLP-1) medications have rapidly ascended...

Read More Read more about Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Deep Dive into Emerging Research

Global Landmarks to Glow Teal, Green, and Pink: The 2026 Push to Fund Metastatic Breast Cancer Research

• Patient Advocacy and Support

Global Landmarks to Glow Teal, Green, and Pink: The 2026 Push to Fund Metastatic Breast Cancer Research

Nana October 10, 2026

NEW YORK, NY — As the world enters the second week of October, a month traditionally synonymous...

Read More Read more about Global Landmarks to Glow Teal, Green, and Pink: The 2026 Push to Fund Metastatic Breast Cancer Research

FDA Expands First-Line Maintenance Options for HER2-Positive Metastatic Breast Cancer: A New Era of Targeted Triple Therapy

• Patient Advocacy and Support

FDA Expands First-Line Maintenance Options for HER2-Positive Metastatic Breast Cancer: A New Era of Targeted Triple Therapy

Iffa Jayyana October 10, 2026

In a landmark decision that promises to reshape the standard of care for patients battling advanced malignancy,...

Read More Read more about FDA Expands First-Line Maintenance Options for HER2-Positive Metastatic Breast Cancer: A New Era of Targeted Triple Therapy

Navigating the Survivorship Gap: Breast Cancer Canada Announces Comprehensive Post-Treatment Webinar Series for October 2026

• Patient Advocacy and Support

Navigating the Survivorship Gap: Breast Cancer Canada Announces Comprehensive Post-Treatment Webinar Series for October 2026

Asep Darmawan October 10, 2026

TORONTO, ON – As the medical community continues to make strides in early detection and targeted therapies,...

Read More Read more about Navigating the Survivorship Gap: Breast Cancer Canada Announces Comprehensive Post-Treatment Webinar Series for October 2026

Bridging Compassion and Care: WHO Director-General’s State Visit to Jordan Highlights Global Health Resilience

• Breast Cancer Prevention and Lifestyle

Bridging Compassion and Care: WHO Director-General’s State Visit to Jordan Highlights Global Health Resilience

Layla Zulfa October 10, 2026

AMMAN, JORDAN — The World Health Organization (WHO) Director-General, Dr. Tedros Adhanom Ghebreyesus, concluded the inaugural day...

Read More Read more about Bridging Compassion and Care: WHO Director-General’s State Visit to Jordan Highlights Global Health Resilience

Biotech Market Pulse: FDA Regulatory Shifts, Obesity Drug Trials, and Strategic Capital Moves

• Treatment Innovations

Biotech Market Pulse: FDA Regulatory Shifts, Obesity Drug Trials, and Strategic Capital Moves

Muslim October 10, 2026

The global biopharmaceutical landscape is undergoing a period of intense scrutiny and strategic recalibration. As regulatory agencies...

Read More Read more about Biotech Market Pulse: FDA Regulatory Shifts, Obesity Drug Trials, and Strategic Capital Moves